Patent details
EP2340308 Title: Combination of dacarbazine and an inhibitor of the TGF-beta system
Basic Information
- Publication number:
- EP2340308
- PCT Application Number:
- PCT/EP/2010/061152
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP107375800
- PCT Publication Number:
- WO/2011/012713
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Combination of dacarbazine and an inhibitor of the TGF-beta system
- French Title of Invention:
- Combinaison de dacarbazine et d'un inhibiteur du système TGF-bêta
- German Title of Invention:
- Kombination aus Dacarbazine und Hemmer des TGF-Betasystems
- SPC Number:
Dates
- Filing date:
- 30/07/2010
- Grant date:
- 24/12/2014
- EP Publication Date:
- 24/12/2014
- PCT Publication Date:
- 03/02/2011
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 06/07/2011
- EP B1 Publication Date:
- 24/12/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 30/07/2015
- Expiration date:
- 30/07/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 30/07/2010
- Name:
- ISARNA Therapeutics GmbH
- Address:
- Leopoldstrasse 254-256, 80807 München, Germany (DE)
Inventor
1
- Name:
- JASCHINSKI Frank
- Address:
- Germany (DE)
2
- Name:
- ROTHAMMER Tanja
- Address:
- Germany (DE)
3
- Name:
- SCHNEIDER Anneliese
- Address:
- Germany (DE)
4
- Name:
- SCHLINGENSIEPEN Karl-Hermann
- Address:
- Germany (DE)
Priority
- Priority Number:
- 09166893
- Priority Date:
- 30/07/2009
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- C12N 15/11;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|